220 related articles for article (PubMed ID: 23467751)
1. Lysophosphatidic acid receptor 4 signaling potentially modulates malignant behavior in human head and neck squamous cell carcinoma cells.
Matayoshi S; Chiba S; Lin Y; Arakaki K; Matsumoto H; Nakanishi T; Suzuki M; Kato S
Int J Oncol; 2013 May; 42(5):1560-8. PubMed ID: 23467751
[TBL] [Abstract][Full Text] [Related]
2. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
[TBL] [Abstract][Full Text] [Related]
3. Lysophosphatidic acid (LPA) signaling via LPA
Takahashi K; Fukushima K; Onishi Y; Inui K; Node Y; Fukushima N; Honoki K; Tsujiuchi T
Biochem Biophys Res Commun; 2017 Jan; 483(1):652-657. PubMed ID: 27993681
[TBL] [Abstract][Full Text] [Related]
4. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family.
Noguchi K; Ishii S; Shimizu T
J Biol Chem; 2003 Jul; 278(28):25600-6. PubMed ID: 12724320
[TBL] [Abstract][Full Text] [Related]
5. Diverse effects of LPA4, LPA5 and LPA6 on the activation of tumor progression in pancreatic cancer cells.
Ishii S; Hirane M; Fukushima K; Tomimatsu A; Fukushima N; Tsujiuchi T
Biochem Biophys Res Commun; 2015 May; 461(1):59-64. PubMed ID: 25849892
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidic acid-induced YAP/TAZ activation promotes developmental angiogenesis by repressing Notch ligand Dll4.
Yasuda D; Kobayashi D; Akahoshi N; Ohto-Nakanishi T; Yoshioka K; Takuwa Y; Mizuno S; Takahashi S; Ishii S
J Clin Invest; 2019 Jul; 129(10):4332-4349. PubMed ID: 31335323
[TBL] [Abstract][Full Text] [Related]
7. Non-Edg family LPA receptors: the cutting edge of LPA research.
Yanagida K; Ishii S
J Biochem; 2011 Sep; 150(3):223-32. PubMed ID: 21746769
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of microRNA-34a expression in head and neck squamous cell carcinoma promotes tumor growth and tumor angiogenesis.
Kumar B; Yadav A; Lang J; Teknos TN; Kumar P
PLoS One; 2012; 7(5):e37601. PubMed ID: 22629428
[TBL] [Abstract][Full Text] [Related]
9. Alpha-2 Heremans Schmid Glycoprotein (AHSG) modulates signaling pathways in head and neck squamous cell carcinoma cell line SQ20B.
Thompson PD; Sakwe A; Koumangoye R; Yarbrough WG; Ochieng J; Marshall DR
Exp Cell Res; 2014 Feb; 321(2):123-32. PubMed ID: 24332981
[TBL] [Abstract][Full Text] [Related]
10. LPA induces osteoblast differentiation through interplay of two receptors: LPA1 and LPA4.
Liu YB; Kharode Y; Bodine PV; Yaworsky PJ; Robinson JA; Billiard J
J Cell Biochem; 2010 Mar; 109(4):794-800. PubMed ID: 20069565
[TBL] [Abstract][Full Text] [Related]
11. Novel anti-tumor mechanism of galanin receptor type 2 in head and neck squamous cell carcinoma cells.
Uehara T; Kanazawa T; Mizukami H; Uchibori R; Tsukahara T; Urabe M; Kume A; Misawa K; Carey TE; Suzuki M; Ichimura K; Ozawa K
Cancer Sci; 2014 Jan; 105(1):72-80. PubMed ID: 24168112
[TBL] [Abstract][Full Text] [Related]
12. Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA
Taniguchi R; Inoue A; Sayama M; Uwamizu A; Yamashita K; Hirata K; Yoshida M; Tanaka Y; Kato HE; Nakada-Nakura Y; Otani Y; Nishizawa T; Doi T; Ohwada T; Ishitani R; Aoki J; Nureki O
Nature; 2017 Aug; 548(7667):356-360. PubMed ID: 28792932
[TBL] [Abstract][Full Text] [Related]
13. Gintonin, newly identified compounds from ginseng, is novel lysophosphatidic acids-protein complexes and activates G protein-coupled lysophosphatidic acid receptors with high affinity.
Hwang SH; Shin TJ; Choi SH; Cho HJ; Lee BH; Pyo MK; Lee JH; Kang J; Kim HJ; Park CW; Shin HC; Nah SY
Mol Cells; 2012 Feb; 33(2):151-62. PubMed ID: 22286231
[TBL] [Abstract][Full Text] [Related]
14. Sprouty2 protein is downregulated in human squamous cell carcinoma of the head and neck and suppresses cell proliferation in vitro.
Lin CL; Chiang WF; Tung CL; Hsieh JL; Hsiao JR; Huang WT; Feng LY; Chang CH; Liu SY; Tsao CJ; Feng YH
Mol Med Rep; 2015 Jan; 11(1):547-54. PubMed ID: 25333206
[TBL] [Abstract][Full Text] [Related]
15. LPA2 (EDG4) mediates Rho-dependent chemotaxis with lower efficacy than LPA1 (EDG2) in breast carcinoma cells.
Chen M; Towers LN; O'Connor KL
Am J Physiol Cell Physiol; 2007 May; 292(5):C1927-33. PubMed ID: 17496233
[TBL] [Abstract][Full Text] [Related]
16. S100A8/A9 (calprotectin) negatively regulates G2/M cell cycle progression and growth of squamous cell carcinoma.
Khammanivong A; Wang C; Sorenson BS; Ross KF; Herzberg MC
PLoS One; 2013; 8(7):e69395. PubMed ID: 23874958
[TBL] [Abstract][Full Text] [Related]
17. Lysophosphatidic Acid Induced Apoptosis, DNA Damage, and Oxidative Stress in Spinal Cord Neurons by Upregulating LPA4/LPA6 Receptors.
Yang Y; Xu J; Su Q; Wu Y; Li Q; Ma Z; Ding T
Mediators Inflamm; 2022; 2022():1818758. PubMed ID: 36248188
[TBL] [Abstract][Full Text] [Related]
18. Effect of the Gintonin-Enriched Fraction on Glucagon-Like-Protein-1 Release.
Lee R; Choi SH; Cho HS; Hwang H; Rhim H; Kim HC; Hwang SH; Nah SY
Molecules; 2021 Oct; 26(20):. PubMed ID: 34684879
[TBL] [Abstract][Full Text] [Related]
19. MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma.
Mohan S; Vander Broek R; Shah S; Eytan DF; Pierce ML; Carlson SG; Coupar JF; Zhang J; Cheng H; Chen Z; Van Waes C
Clin Cancer Res; 2015 Sep; 21(17):3946-56. PubMed ID: 25977343
[TBL] [Abstract][Full Text] [Related]
20. TRIM24 overexpression is common in locally advanced head and neck squamous cell carcinoma and correlates with aggressive malignant phenotypes.
Cui Z; Cao W; Li J; Song X; Mao L; Chen W
PLoS One; 2013; 8(5):e63887. PubMed ID: 23717505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
